Cargando…

Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib

INTRODUCTION: Dogs with allergic dermatitis often suffer concurrent skin and ear infections. The objective of this study was to retrospectively quantify the number of systemic and topical antimicrobial transactions in dogs with allergic dermatitis, following administration of oclacitinib or a glucoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mwacalimba, Kennedy, Hillier, Andrew, Rosenbaum, Michele, Brennan, Christopher, Amodie, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512704/ https://www.ncbi.nlm.nih.gov/pubmed/37745208 http://dx.doi.org/10.3389/fvets.2023.1207582

Ejemplares similares

The Association Between the Use of Oclacitinib and Antibacterial Therapy in Dogs With Allergic Dermatitis: A Retrospective Case-Control Study
por: Rynhoud, Hester, et al.
Publicado: (2021)

Use of Cytopoint in the Allergic Dog
por: Gober, Margaret, et al.
Publicado: (2022)

Pharmacoeconomic Analysis of Heartworm Preventive Compliance and Revenue in Veterinary Practices in the United States
por: Mwacalimba, Kennedy, et al.
Publicado: (2021)

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
por: Cosgrove, Sallie B, et al.
Publicado: (2013)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia
por: Gadeyne, Caroline, et al.
Publicado: (2014)

The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study
por: Rynhoud, Hester, et al.
Publicado: (2022)

Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks
por: Panteri, Alessandro, et al.
Publicado: (2015)

Retrospective Analysis of Heartworm (Dirofilia immitis) Prevention Medication Compliance and Economic Value in Dogs in Veterinary Practices in Australia
por: Mwacalimba, Kennedy, et al.
Publicado: (2021)

Corrigendum: Retrospective Analysis of Heartworm (Dirofilia immitis) Prevention Medication Compliance and Economic Value in Dogs in Veterinary Practices in Australia
por: Mwacalimba, Kennedy, et al.
Publicado: (2021)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015)

Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma
por: Ashton, Laura V., et al.
Publicado: (2023)

Evaluation of topical oclacitinib and nail trimming as a treatment for murine ulcerative dermatitis in laboratory mice
por: Davison, Steven E., et al.
Publicado: (2022)

Side Effects to Systemic Glucocorticoid Therapy in Dogs Under Primary Veterinary Care in the UK
por: Elkholly, Doaa A., et al.
Publicado: (2020)

Evaluation of Skin Prick-Test Reactions for Allergic Sensitization in Dogs With Clinical Symptoms Compatible With Atopic Dermatitis. A Pilot Study
por: Carmona-Gil, Ana M., et al.
Publicado: (2019)

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013)

Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis
por: Chiocchetti, Roberto, et al.
Publicado: (2022)

Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study
por: Barrett, Laura E., et al.
Publicado: (2019)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
por: Koch, Tina, et al.
Publicado: (2016)

Treatment complexity and caregiver burden are linked in owners of dogs with allergic/atopic dermatitis
por: Spitznagel, Mary Beth, et al.
Publicado: (2021)

Dermatological evaluation in dogs with atopic dermatitis treated with full-spectrum high cannabidiol oil: a pre study part 1
por: Mariga, Carollina, et al.
Publicado: (2023)

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
por: Ashton, Laura V, et al.
Publicado: (2020)

Debromoaplysiatoxin as the Causative Agent of Dermatitis in a Dog after Exposure to Freshwater in California
por: Puschner, Birgit, et al.
Publicado: (2017)

Antimicrobial Prescriptions for Dogs in the Capital of Spain
por: Gómez-Poveda, Bárbara, et al.
Publicado: (2018)

Indicators of Health-Related Quality of Life in Cats With Degenerative Joint Disease: Systematic Review and Proposal of a Conceptual Framework
por: Yeowell, Gillian, et al.
Publicado: (2021)

Heartworm prevalence in dogs versus cats: Multiple diagnostic modalities provide new insights
por: Hays, Kellie M., et al.
Publicado: (2020)

A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats
por: Lopes, Natália Lôres, et al.
Publicado: (2019)

Owner and Veterinarian Perceptions About Use of a Canine Quality of Life Survey in Primary Care Settings
por: Mwacalimba, Kennedy K., et al.
Publicado: (2020)

Parenteral Antimicrobial Treatment Diminishes Fecal Bifidobacterium Quantity but Has No Impact on Health in Neonatal Dairy Calves: Data From a Field Trial
por: O'Keefe, Olivia C., et al.
Publicado: (2021)

Quantifying Antimicrobial Exposure in Dogs From a Longitudinal Study
por: Méndez, María, et al.
Publicado: (2020)

Antiepileptic Drug Withdrawal in Dogs with Epilepsy
por: Gesell, Felix Kaspar, et al.
Publicado: (2015)

Is There a Correlation Between Dog Obesity and Human Obesity? Preliminary Findings of Overweight Status Among Dog Owners and Their Dogs
por: Linder, Deborah E., et al.
Publicado: (2021)

Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases
por: Harvey, Richard G., et al.
Publicado: (2022)

A dog lover's dilemma: Airborne allergic contact dermatitis to tylosin
por: Kale, Aditi, et al.
Publicado: (2020)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

Isolation of extraintestinal pathogenic Escherichia coli from diarrheic dogs and their antimicrobial resistance profile
por: de Cleber Jacob Silva Paula,, et al.
Publicado: (2008)

Antimicrobial resistance and genotyping of Pseudomonas aeruginosa isolated from the ear canals of dogs in Japan
por: Elfadadny, Ahmed, et al.
Publicado: (2023)

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
por: Gonzales, A J, et al.
Publicado: (2014)

Inherited Sensory and Autonomic Neuropathy in a Border Collie, Interest of Oclacitinib for the Control of Self-Mutilation
por: Leonard, Caroline, et al.
Publicado: (2022)

Evaluation of Antimicrobial Usage in Dogs and Cats at a Veterinary Teaching Hospital in Germany in 2017 and 2018
por: Schnepf, Anne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n17s0bhg65mjr2oop22uvlr64g